Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IRIS INTERNATIONAL INC (IRIS)
|
Add to portfolio |
|
|
|
| Price: |
$9.46
| | Metrics |
| OS: |
18.1
|
M
| |
1
|
% ROE
|
| Market cap: |
$171
|
M
| |
8
|
% ROIC
|
|
Net cash:
|
$27.2
|
M
| |
$1.50
|
per share
|
|
EV:
|
$144
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$12.0
|
M
| |
12.0
|
x EV/EBITDA
|
|
EBIT
|
$6.6
|
M
| |
21.7
|
x EV/EBIT
|
| EPS |
$0.04
| |
225.4
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| Revenues | 118.3 | 107.7 | 92.6 | 95.5 | 84.3 | 72.1 | 64.6 | 43.7 |
| Revenue growth | 9.9% | 16.3% | -3.1% | 13.3% | 17.0% | 11.6% | 48.0% | 39.3% |
| Cost of goods sold | 58.1 | 52.8 | 43.9 | 46.5 | 42.0 | 37.3 | 33.4 | 22.3 |
| Gross profit | 60.2 | 54.9 | 48.7 | 49.0 | 42.3 | 34.8 | 31.2 | 21.4 |
| Gross margin | 50.9% | 51.0% | 52.6% | 51.3% | 50.2% | 48.3% | 48.4% | 49.0% |
| Sales and marketing | 23.1 | 19.8 | 16.1 | 15.7 | 13.1 | 10.7 | 10.1 | 7.2 |
| Research and development | 16.2 | 14.6 | 11.4 | 10.4 | 10.3 | 13.1 | 5.0 | 3.9 |
| General and administrative | 19.1 | 17.4 | 13.3 | 12.0 | 10.0 | 10.0 | 7.1 | 5.8 |
| EBIT | 3.0 | 3.1 | 7.8 | 11.0 | 9.0 | 1.0 | 8.9 | 4.5 |
| EBIT margin | 2.5% | 2.9% | 8.4% | 11.5% | 10.6% | 1.5% | 13.8% | 10.2% |
| Pre-tax income | -3.1 | 4.1 | 8.7 | 13.4 | 10.4 | 2.1 | 9.5 | 3.8 |
| Income taxes | -1.9 | 1.1 | 2.5 | 4.4 | 2.8 | 2.3 | 3.4 | 1.5 |
| Tax rate | 61.1% | 26.3% | 28.2% | 32.6% | 27.4% | 108.2% | 35.8% | 40.0% |
| Net income | -1.2 | 3.0 | 6.3 | 9.0 | 7.5 | -0.2 | 6.1 | 2.3 |
| Net margin | -1.0% | 2.8% | 6.8% | 9.4% | 9.0% | -0.2% | 9.5% | 5.2% |
| |
| Diluted EPS | ($0.07) | $0.17 | $0.35 | $0.48 | $0.40 | ($0.01) | $0.35 | $0.14 |
| Shares outstanding (diluted) | 17.8 | 18.0 | 17.9 | 18.7 | 18.7 | 17.9 | 17.7 | 15.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|